AGRX News and Press, Agile Therapeutics Inc. From 04/18/22

Penny stocks are well known for their volatility. They’re also known for producing big wins for investors who are willing to take on high-risk trades. This week, the broader markets have gotten off to another choppy start, but that doesn’t seem to have become a concern for sma...

29% increase in Twirla cycles 27% increase in total prescriptions (TRx) of Twirla PRINCETON, N.J., April 14, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced Twirla prescription data for the first quarter 2022...

Top Penny Stocks News on April 13th After Tuesday posed a bearish turnaround for penny stocks and blue chips at midday, investors are hopeful that Wednesday could be different. In the past few trading days, we’ve seen a sizable amount of volatility for penny stocks . This is ...

3 Under $1 Biotech Penny Stocks Flying During Today’s Session Finding biotech penny stocks to buy can be challenging. But, biotech penny stocks are extremely volatile and as a result, they tend to result in either making or losing a lot of money. Some big gainers today alread...

PRINCETON, N.J., April 11, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced the receipt of $4.7 million in net proceeds from the sale of tax benefits pursuant to the Company’s participation in the New Jersey Economic...

PRINCETON, N.J., April 07, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that data from the company’s first-year of postmarketing pharmacovigilance safety surveillance for Twirla ® (levonorgestrel and eth...

Agile Therapeutics has finished its first full year as a commercial company and was able to establish an attractive growth curve for Twirla in several metrics. Slow uptake is forcing me to adjust my investment strategy to avoid locking up my capital while the company is burning throug...

Shares of women's healthcare company Agile Therapeutics (AGRX -11.0%) fell 10% March 31, a day after the company reported its Q4 results. Q4 net revenue more than doubled to $1.51M. However, cost of product revenues in Q4 was $5.7M, which included a $4.5M inventory obsolescence charge fo...

Partners with Award-Winning Director Maya Albanese “Patch and Play” introduces the features of the Twirla (levonorgestrel and ethinyl estradiol) transdermal system, while highlighting the power of female friendships PRINCETON, N.J., March 31, 2022 (GLOBE NEWS...

Image source: The Motley Fool. Agile Therapeutics (NASDAQ: AGRX) Q4 2021 Earnings Call Mar 30, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Agile Therapeutics (AGRX) Q4 2021 Earnings Call Transcript